Literature DB >> 17632780

Disclosures of Huntington disease risk within families: patterns of decision-making and implications.

Robert Klitzman1, Deborah Thorne, Jennifer Williamson, Wendy Chung, Karen Marder.   

Abstract

Patterns of disclosure of Huntington disease risk and genetic test results among family members are important, but have been underexplored. We interviewed 21 individuals in-depth - eight mutation-positive for HD, four mutation-negative, and nine not tested - for 2 hr each. Within families, critical questions arose of what, when, and to whom to disclose, and what to do post-disclosure. Interviewees wrestled with dilemmas of what to tell (e.g., suspicions vs. confirmed symptoms; initiation vs. completion of testing; partial vs. indirect information), how to disclose (e.g., planning in advance vs. "blurting out" information in arguments), and whether and how to tell extended family members. Questions arose of when to tell (i.e., to avoid disclosing "too early" or "too late"). Similarities and differences emerged related to types of relationships (e.g., parents telling offspring vs. offspring telling parents vs. siblings telling each other). Individuals often disclosed because of perceived duty to foster the health of their family members, enabling these others to pursue appropriate medical evaluation, if desired. Yet tensions arose because the information could burden these members, who also have rights to remain "in denial" if they wish and not discuss the topic or pursue testing. Post-disclosure, dilemmas emerged of whether and how much to encourage family members to pursue testing. These data shed important light on critical issues that have received little, if any, attention concerning what, how, and when disclosure occurs, and have key implications for at-risk individuals, genetic counselors, and other health care workers (HCWs), and for future research. At-risk individuals would benefit from considering these issues in advance. HCWs need to realize that these decisions are multi-faceted. Future research can explore whether, when, how, and how often HCWs raise these issues with individuals. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17632780     DOI: 10.1002/ajmg.a.31864

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  22 in total

1.  Factors associated with experiences of genetic discrimination among individuals at risk for Huntington disease.

Authors:  Yvonne Bombard; JoAnne Palin; Jan M Friedman; Gerry Veenstra; Susan Creighton; Jane S Paulsen; Joan L Bottorff; Michael R Hayden
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-11-10       Impact factor: 3.568

2.  Duchenne Muscular Dystrophy: a Survey of Perspectives on Carrier Testing and Communication Within the Family.

Authors:  Brenna Hayes; Susan Hassed; Jae Lindsay Chaloner; Christopher E Aston; Carrie Guy
Journal:  J Genet Couns       Date:  2015-10-19       Impact factor: 2.537

3.  Rural Mexican-Americans' perceptions of family health history, genetics, and disease risk: implications for disparities-focused research dissemination.

Authors:  Rachel Malen; Sarah Knerr; Fernanda Delgado; Stephanie M Fullerton; Beti Thompson
Journal:  J Community Genet       Date:  2015-07-04

Review 4.  Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials.

Authors:  Scott Y H Kim; Jason Karlawish; Benjamin E Berkman
Journal:  Neurology       Date:  2015-03-11       Impact factor: 9.910

5.  The process of deciding about prophylactic surgery for breast and ovarian cancer: Patient questions, uncertainties, and communication.

Authors:  Robert Klitzman; Wendy Chung
Journal:  Am J Med Genet A       Date:  2010-01       Impact factor: 2.802

6.  Views of discrimination among individuals confronting genetic disease.

Authors:  Robert Klitzman
Journal:  J Genet Couns       Date:  2010-02       Impact factor: 2.537

7.  A family genetic risk communication framework: guiding tool development in genetics health services.

Authors:  Miriam E Wiens; Brenda J Wilson; Christina Honeywell; Holly Etchegary
Journal:  J Community Genet       Date:  2013-01-15

8.  Fear of health insurance loss among individuals at risk for Huntington disease.

Authors:  Emily Oster; E Ray Dorsey; Jan Bausch; Aileen Shinaman; Elise Kayson; David Oakes; Ira Shoulson; Kimberly Quaid
Journal:  Am J Med Genet A       Date:  2008-08-15       Impact factor: 2.802

9.  The impact of social roles on the experience of men in BRCA1/2 families: implications for counseling.

Authors:  Mary B Daly
Journal:  J Genet Couns       Date:  2008-08-08       Impact factor: 2.537

10.  The impact of social contexts in testing for alpha-1 antitrypsin deficiency: the roles of physicians and others.

Authors:  Robert Klitzman
Journal:  Genet Test Mol Biomarkers       Date:  2009-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.